{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T18:22:44Z","timestamp":1748197364276,"version":"3.37.3"},"reference-count":15,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Scientific Research Foundation Flanders","award":["12Y2420N","1S69921N"],"award-info":[{"award-number":["12Y2420N","1S69921N"]}]},{"name":"Innovation and Clinical Research Fund of the Ghent University Hospital","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Basal cell carcinomas (BCCs) represent 70% of all skin cancers. These tumours do not metastasise but are locally invasive if left untreated. There is a high incidence of BCC in the elderly, and clinicians frequently face important treatment dilemmas. The approach to BCC in the elderly should be investigated thoroughly.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>Data on health-related quality of life (HrQoL), survival and complication rate will be examined in a treatment and a non-treatment arm (1:1 allocation). In the non-treatment arm, in vivo biological behaviour of low-risk BCCs in elderly patients will be examined. The main objective is to combine tumour characteristics with demographic data, in order to determine whether treatment will positively affect the patients\u2019 HrQoL within a predetermined time frame. A monocentric randomised controlled trial (RCT) was designed at the Ghent University Hospital. The study population consists of patients with the minimum age of 75 years and a new diagnosis of (a) low-risk BCC(s). Patients in the treatment arm will receive standard care. Patients in the non-treatment arm will be closely monitored: the tumour will be intensively evaluated using multispectral dermoscopy, reflectance confocal microscopy and high-definition optical coherence tomography. All patients will be asked to fill in a questionnaire concerning their HrQoL at consecutive time points. Patient-reported side effects will be evaluated via an additional questionnaire.<\/jats:p><jats:p>Primary outcomes will include the difference in HrQoL and the difference in complication risks (treatment vs non-treatment) at different time points of the study. Secondary endpoints are the evolution of the BCCs in the non-treatment arm and the long-term survival in both study arms. Tertiary endpoint is the treatment effectiveness in the treatment arm. The sample size calculation was performed and resulted in a target sample size of 272 patients in this study with a 1:1 allocation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>Subjects can withdraw from participating in this study at any time for any reason without any consequences. Approval for this study was received from the Ethics Committee of the Ghent University Hospital on 26 August 2021.The results of this RCT will be submitted for publication in one or more international, peer-reviewed medical journals, regardless of the nature of the study results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>ClinicalTrials.gov (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05110924\">NCT05110924<\/jats:ext-link>).<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2022-063526","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T15:00:56Z","timestamp":1668092456000},"page":"e063526","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Study protocol of the BASINEL Study: a pragmatic randomised controlled trial investigating treatment versus no treatment of low-risk basal cell carcinomas in older persons"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct05110924","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8072-6041","authenticated-orcid":false,"given":"Laura","family":"Van Coile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"Verhaeghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Ongenae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lieve","family":"Brochez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Hoorens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"2022120903401558000_12.11.e063526.1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2340\/00015555-1009","article-title":"Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands","volume":"91","author":"Flohil","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"2022120903401558000_12.11.e063526.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2016.10.005"},{"key":"2022120903401558000_12.11.e063526.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.23591.x"},{"key":"2022120903401558000_12.11.e063526.4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamadermatol.2016.3628","article-title":"The epidemiology and clinicopathological features of basal cell carcinoma in patients 80 years and older: a systematic review","volume":"153","author":"Lubeek","year":"2017","journal-title":"JAMA Dermatol"},{"key":"2022120903401558000_12.11.e063526.5","unstructured":"Publications - United Nations Population Division | Department of Economic and Social Affairs. Available: https:\/\/www.un.org\/en\/development\/desa\/population\/publications\/index.asp"},{"key":"2022120903401558000_12.11.e063526.6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bjd.21056","article-title":"Basal cell carcinoma in older adults: how to decide when active surveillance or watchful waiting is appropriate?","volume":"187","author":"Van Coile","year":"2022","journal-title":"Br J Dermatol"},{"key":"2022120903401558000_12.11.e063526.7","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jamainternmed.2013.639","article-title":"Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer","volume":"173","author":"Linos","year":"2013","journal-title":"JAMA Intern Med"},{"key":"2022120903401558000_12.11.e063526.8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.2014.9655","article-title":"Potential overdiagnosis of basal cell carcinoma in older patients with limited life expectancy","volume":"312","author":"Linos","year":"2014","journal-title":"JAMA"},{"key":"2022120903401558000_12.11.e063526.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2022120903401558000_12.11.e063526.10","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jdcr.2018.09.019","article-title":"Introduction to reflectance confocal microscopy and its use in clinical practice","volume":"4","author":"Levine","year":"2018","journal-title":"JAAD Case Rep"},{"key":"2022120903401558000_12.11.e063526.11","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/jdv.13712","article-title":"A meta-analysis of reflectance confocal microscopy for the diagnosis of malignant skin tumours","volume":"30","author":"Xiong","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022120903401558000_12.11.e063526.12","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.3390\/jcm8091462","article-title":"A systematic review and meta-analysis of the accuracy of in VivoReflectance confocal microscopy for the diagnosis of primary basal cell carcinoma","volume":"8","author":"Lupu","year":"2019","journal-title":"J Clin Med"},{"key":"2022120903401558000_12.11.e063526.13","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/srt.12859","article-title":"Enhanced visualization of blood and pigment in multispectral skin dermoscopy","volume":"26","author":"Janssen","year":"2020","journal-title":"Skin Res Technol"},{"key":"2022120903401558000_12.11.e063526.14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s13671-019-00269-y","article-title":"Non-Invasive imaging for skin Cancers\u2014the European experience","volume":"8","author":"Guida","year":"2019","journal-title":"Curr Dermatol Rep"},{"key":"2022120903401558000_12.11.e063526.15","doi-asserted-by":"publisher","DOI":"10.1117\/1.JBO.23.1.010504"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-063526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T11:42:04Z","timestamp":1670586124000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-063526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":15,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,10]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1136\/bmjopen-2022-063526"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-063526","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}